[144] Adaptive Biotechnologies Corp SEC Filing
Rhea-AI Filing Summary
Harlan Robins submitted a Rule 144 notice to sell 10,000 shares of Common Stock on 04/08/2026.
The filing also lists recent compensatory issuances: 47,504, 41,246, and 11,250 shares were recorded as "Acquired as compensation -- Performance Awards" on 03/07/2026. A header line shows 160,044,392 shares with an associated date of 06/15/2026 as a contextual figure.
Positive
- None.
Negative
- None.
Insights
Notice filed under Rule 144 reporting a sale of 10,000 shares by Harlan Robins.
Rule 144 notices are procedural disclosures of intended or completed sales by affiliates or holders relying on the exemption; the filing records a 10,000-share sale dated 04/08/2026. The document also documents compensatory awards dated 03/07/2026, which may affect available resale limitations.
The practical compliance issues are timing and holding-period requirements; subsequent public filings or broker reports will show whether the sale occurred in compliance with Rule 144 conditions.
Small-volume Rule 144 notice; compensatory grants noted the prior month.
The 10,000-share listed sale is modest relative to the header figure of 160,044,392 shares shown with date 06/15/2026. The filing also records three compensatory issuances on 03/07/2026 totaling 99,000 shares across listed awards (47,504; 41,246; 11,250).
On its face, this is routine disclosure; trading impact depends on execution details and whether the sale was completed under Rule 144 conditions.